Family Medicine Governments Legal Medical Specialties News Policy Strategy WHO

U.N. agency says coronavirus emergency could trump some patent rights

Discussions are underway on enabling wider access to some patented drugs and medical supplies during the coronavirus pandemic, the head of the U.N.’s intellectual property agency said on Tuesday.

Francis Gurry, director-general of the World Intellectual Property Organization (WIPO), said that during an emergency, health and safety “trumps everything”.

World Health Organization (WHO) director-general Tedros Adhanom Ghebreyesus said on Monday that he backed a proposal by Costa Rica’s President Carlos Alvarado to “create a pool of rights to tests, medicines and vaccines, with free access or licensing on reasonable and affordable terms for all countries”.

“We are working with Costa Rica to finalise the details,” Tedros told reporters.

WIPO’s Gurry, asked about demands for access to drugs and compulsory licensing, told a separate news conference: “This is a hot issue, and it’s a very sensitive issue as well.”

But extraordinary situations call for “extraordinary measures”, he said, adding: “The international legal framework does foresee a certain number of flexibilities for countries to be able to deal with health in particular and health emergencies.

“If they are targeted, such as the compulsory license situation, a very specific compulsory license on a very specific product to ensure the supply of product in the market, that’s arguably the sort of action that we need,” he said.

A “non-legislative mechanism” would be a “great way forward”, Gurry said, adding: “Let’s look at the practical measures that can make a difference here. And of course we are involved discussions with various parties to see what might be done in this regard.”

The World Trade Organization’s so-called TRIPS agreement (Trade-Related Intellectual Property Rights) essentially allows countries during an emergency to grant “compulsory licenses” to companies to produce a patented product.

Read More

Meeta Ramnani
Meeta Ramnani
Meeta develops credible content about various markets based on deep research, opinions from experts and inputs from industry leaders. As the managing editor at Smart Industry News, she assures that every piece of news and article adds to the knowledge of decision makers. An avid bike rider, Meeta, is a postgraduate from Indian Institute of Journalism and New Media (IIJNM) Bangalore, where her specialization was Business Journalism. She carries experience from mainstream print media including The Times Group and Sakal Media Group.
https://smarthealthcarenews.com/